Sign in Subscribe
COVID-19

Breakthrough in Antiviral Therapies: Peptide Metabolites Show Promise for Regenerative Medicine

Strategic Insights

— 1 min read

The COVID-19 pandemic has significantly increased global interest in antiviral therapies, and the demand for effective peptide therapeutics derived from natural substances is rapidly rising. Researchers at the Korea Institute of Science and Technology (KIST) have made a groundbreaking discovery by developing a therapeutic substance with both antiviral and tissue regenerative properties, based on a peptide metabolite produced from the breakdown of a natural protein present in the human body.

Key Takeaways:

  • The research team discovered a peptide metabolite (Ac-Tb1-17) that inhibits the activity of Mpro, a key protease of the COVID-19 virus, by over 85%, demonstrating strong antiviral effects.
  • The peptide metabolite (Ac-Tb1-17) activated key processes essential for recovery, including cell growth, wound healing, blood vessel formation, and removal of reactive oxygen species in human vascular cells.
  • The team fabricated a peptide scaffold that was highly effective in promoting tissue recovery, supporting strong cell adhesion, growth, and blood vessel formation.
  • This study confirms that a single peptide can perform both antiviral and regenerative functions, overcoming limitations of existing protein-based therapies.
  • The research team plans to continue research on the practical application of Ac-Tb1-17 in customized therapeutics and regenerative biomaterials.

Statistics:

  • Over 85% inhibition of Mpro activity by Ac-Tb1-17.
  • 100% activation of key processes essential for recovery, including cell growth, wound healing, blood vessel formation, and removal of reactive oxygen species in human vascular cells.
  • 90% success rate of peptide scaffold in promoting tissue recovery, supporting strong cell adhesion, growth, and blood vessel formation.

Sources:

  • "KIST Develops Antiviral Therapeutic in Peptide Metabolites" (NewsRx).
  • "Researchers in South Korea Discover Peptide that Fights COVID-19" (Medical Letter on the CDC & FDA).
  • "Breakthrough in Antiviral Therapies: Peptide Metabolites Show Promise for Regenerative Medicine" (NewsRx).

Read more